Pharmaceutical compositions comprising a soluble interleukin-4 r

Details Pharmaceutical compositions comprising a soluble interleukin-4 r Pharmaceutical compositions comprising a soluble interleukin-4 r

1996-09-16

2000-05-16

Mertz, Prema

Drug, bio-affecting and body treating compositions

Lymphokine

Interleukin

514 2, 514 8, 514 12, 514885, A61K 3817, A61K 3820

Patent

active

060633719

ABSTRACT:
The biological activity of exogenous ligand proteins is enhanced by intravenously co-administering to a mammal the ligand and a soluble receptor protein that binds thereto. Pharmaceutical compositions comprising a ligand protein complexed with a soluble receptor protein are provided. In certain embodiments, the ligand is selected from the group consisting of interleukins, colony stimulating factors, and tumor necrosis factor.

REFERENCES:
patent: 4707443 (1987-11-01), Nelson et al.
patent: 5057417 (1991-10-01), Hammonds et al.
patent: 5116951 (1992-05-01), Druez et al.
patent: 5180678 (1993-01-01), Druez et al.
patent: 5180812 (1993-01-01), Dower et al.
patent: 5194375 (1993-03-01), Park et al.
patent: 5216128 (1993-06-01), Novick et al.
Callard et al. The Cytoleine Facts Book, Academic Press Inc. 1994, p. 64.
Sato et al., "Recombinant Soluble Murine IL-4 Receptor Can Inhibit or Enhe IgE Responses in Vivo, " Journal of Immunology 150 (7):2717-2723, 1991.
Karavodin, L.M., and L.P. Courtney, Abstracts of the 8th International Congress of Immunology, Springer-Verlag, Budapest, p. 220;1992.
Honda et al., The Journal of Immunology, 148:2178-2180, No. 7;1992.
Aderka et al., J. Exp. Med., 175:323-329; 1992.
Ashkenazi et al., Proc. Natl. Acad. Sci. USA, 88:10535-10539; 1991.
Fernandez-Botran et al., J. Exp. Med., 174:673-684; 1991.
Jacobs et al., Blood, 77:2396-2403; 1991.
Lesslauer et al., Eur. J. Immunol., 21:2883-2886; 1991.
Fernandez-Botran et al., The FASEB Journal, 5:2567-2574; 1991.
Dower et al., Jounal of Clinical Immunology, 10:289-299; 1990.
Maliszewski et al., The Journal of Immunology, 144:3028-3033; 1990.
Mosely et al., Cell, 59:335-348; 1989.
Urdal, et al., Behring Inst. Mitt., 83:27-29; 1988.
Baumann, et al., Journal of Clinical Endocrinology and Metabolism, 64:657-660; 1987.
Rosenblum, et al., Cancer Research, 45:2421-2424; 1985.

Affiliated with

Also associated with

Rating

Pharmaceutical compositions comprising a soluble interleukin-4 r does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical compositions comprising a soluble interleukin-4 r, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions comprising a soluble interleukin-4 r will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-256281